Loading...
The value of radiotherapy for rectal cancer.
James, Roger D Schofield, Philip F
James, Roger D
Schofield, Philip F
Citations
Altmetric:
Abstract
Discrepancies in morbidity and local recurrence rates in published clinical trials of pelvic XRT for colorectal cancer are caused by a variety of complex factors. It is, however, clear that XRT is able to cure early rectal carcinomas and is particularly useful in alleviating the symptoms of advanced or recurrent disease. The selection of appropriate cases for combinations of XRT and surgery can be made on the basis of digital examination under anaesthetic. One aim of these combinations is to reduce the number of patients with mobile tumours of the lower two-thirds of the rectum who require a permanent colostomy. In the absence of effective chemotherapy for metastatic disease, liver XRT may have a place in controlling the growth rate of occult liver metastases in selected patients.
Authors
Affiliation
Description
Date
1989-07
Publisher
Collections
Keywords
Colorectal Cancer
Type
Article
Citation
The value of radiotherapy for rectal cancer. 1989, 3 (3):647-69 Baillieres Clin Gastroenterol